Arkea Bio Corp. — Form D
Arkea Bio Corp. of CHARLESTOWN, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-14. The offering totals $12.0M, of which $7.0M was reported sold. Industry: Other Technology.
Offering
- Filed: 2025-10-14
- Form: D
- Accession: 0002004801-25-000002
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $12.0M
- Amount sold: $7.0M
- Remaining: $5.0M
- Investors: 2
- Date of first sale: 2025-09-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-560632
Issuer
- Name: Arkea Bio Corp.
- CIK: 0002004801
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 500 RUTHERFORD AVE, CHARLESTOWN, MA, 02129
- Phone: (833) 275-3224
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Wayne McNee | Director | Charlestown, MA |
| Chris Rivest | Director | Charlestown, MA |
| Zachariah Serber | Director | Charlestown, MA |
| Frank Wooten | Director | Charlestown, MA |
| Chris Rivest | Executive Officer | Charlestown, MA |
| Zachariah Serber | Executive Officer | Charlestown, MA |
| Frank Wooten | Executive Officer | Charlestown, MA |
| Matthew Dunn | Executive Officer | Akron, OH |
| Ginja Silva | Executive Officer | Charlestown, MA |
| Colin South | Director | Charlestown, MA |
| Colin South | Executive Officer | Charlestown, MA |
Other filings by this issuer (1)
More